KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Account Payables (2016 - 2025)

Globus Medical's Change in Account Payables history spans 15 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 44.16% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $8.5 million, down 51.95%, while the annual FY2025 figure was $8.5 million, 51.95% down from the prior year.
  • Change in Account Payables reached $9.1 million in Q4 2025 per GMED's latest filing, up from $3.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $17.3 million in Q2 2024 to a low of -$10.3 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $1.5 million, with a median of $473500.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: skyrocketed 1588.34% in 2021, then plummeted 811.11% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $1.2 million in 2021, then soared by 244.88% to $4.0 million in 2022, then crashed by 256.35% to -$6.3 million in 2023, then soared by 361.03% to $16.4 million in 2024, then plummeted by 44.16% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Change in Account Payables are $9.1 million (Q4 2025), $3.4 million (Q3 2025), and -$3.2 million (Q2 2025).